ESSEBAG, Vidal

$180,000.00 CAD

≈ 2 Canadians' average pay for a year
Department
Canadian Institutes of Health Research
Program
Recipient country
Canada
Fiscal year
2013-2014
Agreement period
July 1, 2013 – June 30, 2016
Reference
cihr-irsc:236-2013-2014-Q1-00052

Published purpose

BRUISE CONTROL-2: A randomized controlled trial to investigate whether a strategy of Continued versus Interrupted Dabigatran at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events, leads to a reduction in the incidence of clinically significant hematoma

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions